These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33793054)

  • 1. Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation.
    Lai Q; Magistri P; Lionetti R; Avolio AW; Lenci I; Giannelli V; Pecchi A; Ferri F; Marrone G; Angelico M; Milana M; Schinniná V; Menozzi R; Di Martino M; Grieco A; Manzia TM; Tisone G; Agnes S; Rossi M; Di Benedetto F; Ettorre GM;
    Liver Int; 2021 Jul; 41(7):1629-1640. PubMed ID: 33793054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation.
    Marrone G; Giannelli V; Agnes S; Avolio AW; Baiocchi L; Berardi G; Ettorre GM; Ferri F; Corradini SG; Grieco A; Guglielmo N; Lenci I; Lionetti R; Mennini G; Milana M; Rossi M; Spoletini G; Tisone G; Manzia TM; Lai Q
    Liver Int; 2024 Jan; 44(1):103-112. PubMed ID: 37752798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Lai JC; Covinsky KE; Dodge JL; Boscardin WJ; Segev DL; Roberts JP; Feng S
    Hepatology; 2017 Aug; 66(2):564-574. PubMed ID: 28422306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada.
    Renfrew PD; Quan H; Doig CJ; Dixon E; Molinari M
    Can J Gastroenterol; 2011 Jul; 25(7):359-64. PubMed ID: 21876856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Kardashian A; Ge J; McCulloch CE; Kappus MR; Dunn MA; Duarte-Rojo A; Volk ML; Rahimi RS; Verna EC; Ganger DR; Ladner D; Dodge JL; Boyarsky B; McAdams-DeMarco M; Segev DL; Lai JC
    Hepatology; 2021 Mar; 73(3):1132-1139. PubMed ID: 32491208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective.
    Cavaggioni G; Poli E; Ferri F; Parlati L; Monaco V; Melcore C; Lattanzi B; Merli M; Mennini G; Melandro F; Rossi M; Ginanni Corradini S
    Metab Brain Dis; 2017 Jun; 32(3):923-933. PubMed ID: 28397153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposing a Sex-Adjusted Sodium-Adjusted MELD Score for Liver Transplant Allocation.
    Sealock JM; Ziogas IA; Zhao Z; Ye F; Alexopoulos SP; Matsuoka L; Chen G; Davis LK
    JAMA Surg; 2022 Jul; 157(7):618-626. PubMed ID: 35583884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of MELD3.0 in 2 centers from different continents.
    Tejedor M; Bellón JM; Fernández de la Varga M; Peralta P; Montalvá E; Selzner N; Berenguer M
    Hepatol Commun; 2024 Aug; 8(8):. PubMed ID: 39082971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
    Tejedor M; Selzner N; Berenguer M
    Transplantation; 2022 Nov; 106(11):2122-2136. PubMed ID: 35594480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint modeling of liver transplant candidates outperforms the model for end-stage liver disease: The effect of disease development over time on patient outcome.
    Goudsmit BFJ; Braat AE; Tushuizen ME; Vogelaar S; Pirenne J; Alwayn IPJ; van Hoek B; Putter H
    Am J Transplant; 2021 Nov; 21(11):3583-3592. PubMed ID: 34174149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.
    Kim JJ; Kim JH; Koo JK; Choi YJ; Ko SY; Choe WH; Kwon SY
    Clin Mol Hepatol; 2014 Mar; 20(1):47-55. PubMed ID: 24757658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas.
    Molinari M; Renfrew PD; Petrie NM; De Coutere S; Abdolell M
    Transpl Int; 2011 Mar; 24(3):292-9. PubMed ID: 21143650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.
    Myers RP; Shaheen AA; Faris P; Aspinall AI; Burak KW
    PLoS One; 2013; 8(1):e51926. PubMed ID: 23349678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
    Li JY; Deng Q; Wang Y; Xu MY; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis.
    Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U
    Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
    Biselli M; Gramenzi A; Lenzi B; Dall'Agata M; Pierro ML; Perricone G; Tonon M; Bellettato L; D'Amico G; Angeli P; Boffelli S; Bonavita ME; Domenicali M; Caraceni P; Bernardi M; Trevisani F
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1388-1397.e1. PubMed ID: 30557740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.